Browsing: Conditions

A grassroots team of researchers just cracked open a new frontier in drug development – one that Big Pharma hasn’t bothered with. Working nights and weekends with cobbled-together funding, they’ve demonstrated how quantum computing paired with AI can generate novel peptides to treat rare diseases and help underserved populations. The breakthrough, detailed by Wired, shows…

COMBINED tau biomarkers track early cognitive decline and forecast structural neurodegeneration in preclinical Alzheimer’s disease. Clinicians evaluating asymptomatic individuals with confirmed amyloid-beta deposition frequently face significant prognostic challenges due to variable disease trajectories. While plasma biomarkers offer high diagnostic sensitivity, they lack spatial precision regarding fibrillar protein localization in specific neural tissues. To address these…